USPTO TTABVUE. Trademark Trial and Appeal Board Inquiry System

	United States Patent and Trademark Office
	Home\|Site Index\|Search\|Guides\|Contacts\|eBusiness\|eBiz alerts\|News\|Help

TTABVUE. Trademark Trial and Appeal Board Inquiry System

v2.5.0

Summary

Query: Party Name contains all words: GLAXO GROUP LIMITED
Number of results: 101+
Results are in reverse chronological order

Proceeding
Filing Date

Defendant(s),
Property(ies)

Plaintiff(s),
Property(ies)

87001096
07/05/2016

Glaxo Group Limited
Mark: VIDIATROL S#:87001096

Alkermes, Inc.

86908843
06/28/2016

WOCKHARDT BIO AG
Mark: PEFTAZ S#:86908843

Glaxo Group Limited

86851032
06/06/2016

Ipsen Pharma S.A.S.
Mark: FORLAX S#:86851032

Glaxo Group Limited

86765750
05/12/2016

Glaxo Group Limited
S#:86765750

Sandoz Inc.

86765738
05/12/2016

Glaxo Group Limited
S#:86765738

NEUTEC ILAC SANAYI TICARET ANONIM SIRKETI
NEUTEC ARGE SANAYI VE TICARET ANONIM SIRKETI
Mahmut Bilgic
NEUTEC INHALER ILAC SAN. VE TIC. A.S.
LINEX GMBH
Sandoz Inc.

86825495
03/31/2016

Glaxo Group Limited
Mark: SOZIABA S#:86825495

Merck Sharp & Dohme Corp.

91226812
03/10/2016

Glaxo Group Limited
Mark: VUZALPEX S#:86705282

Alpex Pharma SA
Mark: ALPEX S#:78461054 R#:3103109

86642009
02/12/2016

Glaxo Group Limited
Mark: VOBRECTIS S#:86642009

Novartis AG

86736639
01/14/2016

Glaxo Group Limited
Mark: TARLYZO S#:86736639

DAIICHI SANKYO COMPANY, LIMITED

91224991
11/24/2015

Ansun Biopharma, Inc.
Mark: FLUDASE S#:86336849

Glaxo Group Limited
Mark: FLONASE S#:74389190 R#:1870977

86663738
11/13/2015

Glaxo Group Limited
Mark: ZINTERIO S#:86663738

Boehringer Ingelheim International GmbH

86647412
11/06/2015

Glaxo Group Limited
Mark: NUVOV S#:86647412

Gilead Sciences Ireland UC

86641987
11/06/2015

Glaxo Group Limited
Mark: STEZIPLA S#:86641987

Bristol-Myers Squibb & Gilead Sciences, LLC

91224098
09/29/2015

Glaxo Group Limited
Mark: KYBRELLON S#:86348038

Kythera Biopharmaceuticals, Inc.
Mark: KYBELLA S#:86128553 R#:4795973

86349554
07/15/2015

Glaxo Group Limited
Mark: SAXEFAR S#:86349554

Novo Nordisk A/S

86336849
07/08/2015

Ansun Biopharma, Inc.
Mark: FLUDASE S#:86336849

Glaxo Group Limited

86348038
06/30/2015

Glaxo Group Limited
Mark: KYBRELLON S#:86348038

Kythera Biopharmaceuticals, Inc.

86441285
04/30/2015

IGI Laboratories, Inc.
Mark: CEFOTAN S#:86441285

Glaxo Group Limited

86427273
03/18/2015

Glaxo Group Limited
Mark: SENSIMIST S#:86427273

GILEAD SCIENCES IRELAND UC

86365254
01/19/2015

Glaxo Group Limited
Mark: GADEPTA S#:86365254

Novartis AG

91219967
12/30/2014

Relypsa, Inc.
Mark: RELYZAR S#:86235829

Glaxo Group Limited
Mark: RELENZA S#:78452022 R#:3049319
Mark: RELENZA IV S#:86195436

85482680
12/18/2014

WESTPORT PHARMACEUTICALS, LLC
Mark: RELEVA S#:85482680

Glaxo Group Limited

86347994
12/17/2014

Glaxo Group Limited
Mark: ENFIFEO S#:86347994

Millennium Pharmaceuticals, Inc.

86303653
11/12/2014

Glaxo Group Limited
Mark: MYAVNA S#:86303653

Novartis AG

91219081
10/29/2014

Glaxo Group Limited
Mark: VELEXITY S#:86109398

Actelion Pharmaceuticals Ltd.
Mark: VELETRI S#:76289963 R#:2720582
Mark: VELETRI S#:79070519 R#:3818540